Announcements Trials

Browse Landscape

Phase

Phase 1 3 Phase NA 2 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Stomach Neoplasms 1 Pancreatic Adenocarcinoma 1 Pain 1 Neoplasm Metastasis 1 NSCLC 1 Lymphatic Metastasis 1 Colorectal Neoplasms 1 Castration-resistant Prostate Cancer Patients with Oligometastases 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma 1

Interventions

Oxaliplatin 2 Fluorouracil 2 rubitecan 1 nimotuzumab 1 halofantrine 1 gallium 68 PSMA-11 1 camrelizumab 1 apatinib 1 S 1 (combination) 1 Radiotherapy 1 Radiosurgery 1 Radiation 1 Photochemotherapy 1 Nadroparin 1 Heparin, Low-Molecular-Weight 1 Gastrectomy 1 Esophagectomy 1 Docetaxel 1 Cisplatin 1 Chemoradiotherapy 1 Capecitabine 1 CP protocol 1 Brachytherapy 1 Atrasentan 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Adenocarcinoma × Radiosurgery × Clear all

NCT07426055 2026-03-23

PRO-BOOST-LC

Affidea Nu-med Center of Oncological DIagnostics and Therapy

Phase 2/3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡